Added Value of Antigen ELISA in the Diagnosis of Neurocysticercosis in Resource Poor Settings

PLoS Neglected Tropical Diseases

Volumn 6, Issue 10, 2012, Pages

  Gabriël, Sarah ^a   Blocher, Joachim ^b,c   Dorny, Pierre ^a   Abatih, Emmanuel Nji ^a   Schmutzhard, Erich ^b   Ombay, Michaeli ^d   Mathias, Bartholomayo ^d   Winkler, Andrea Sylvia ^e  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^d HAYDOM LUTHERAN HOSPITAL   (Tanzania)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; PARASITE ANTIGEN;

ADOLESCENT; ANTIGEN DETECTION; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOELECTROTRANSFER BLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NEUROCYSTICERCOSIS; NEUROIMAGING; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; TAENIA;

ANTIBODIES, HELMINTH; ANTIBODIES, MONOCLONAL; ANTIGENS, HELMINTH; CLINICAL LABORATORY TECHNIQUES; DEVELOPING COUNTRIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NEUROCYSTICERCOSIS; PARASITOLOGY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84869034352     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001851     Document Type: Article

References (32)

1. Preux PM, Druet-Cabanac M, (2005) Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 4: 21-31.
2. Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR, (2010) Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 51: 883-890.
3. Meyer AC, Dua T, Ma J, Saxena S, Birbeck G, (2010) Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 88: 260-266.
4. Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, et al. (2010) A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 4: e870.
5. Tsang VC, Brand JA, Boyer AE, (1989) An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 159: 50-59.
6. Deckers N, Dorny P, (2010) Immunodiagnosis of Taenia solium taeniosis/cysticercosis. Trends Parasitol 26: 137-144.
7. da Silva Ribeiro V, Manhani MN, Cardoso R, Vieira CU, Goulart LR, et al. (2010) Selection of high affinity peptide ligands for detection of circulating antibodies in neurocysticercosis. Immunol Lett 129: 94-99.
8. Sahu PS, Parija SC, Jayachandran S, (2010) Antibody specific to 43 kDa excretory-secretory antigenic peptide of Taenia solium metacestode as a potential diagnostic marker in human neurocysticercosis. Acta Trop 115: 257-261.
9. Manhani MN, Ribeiro VS, Cardoso R, Ueira-Vieira C, Goulart LR, et al. (2011) Specific phage-displayed peptides discriminate different forms of neurocysticercosis by antibody detection in the serum samples. Parasite Immunol 33: 322-329.
10. Dorny P, Brandt J, Geerts S, (2004) Immunodiagnostic approaches for detecting Taenia solium. Trends Parasitol 20: 259-260.
11. Fleury A, Hernandez M, Avila M, Cardenas G, Bobes RJ, et al. (2007) Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis. J Neurol Neurosurg Psychiatry 78: 970-974.
12. Praet N, Rodriguez-Hidalgo R, Speybroeck N, Ahounou S, Benitez-Ortiz W, et al. (2010) Infection with versus exposure to Taenia solium: what do serological test results tell us? Am J Trop Med Hyg 83: 413-415.
13. Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, et al. (2001) Proposed diagnostic criteria for neurocysticercosis. Neurology 57: 177-183.
14. Nash TE, Garcia HH, (2011) Diagnosis and treatment of neurocysticercosis. Nature reviews Neurology 7: 584-594.
15. Winkler AS, Blocher J, Auer H, Gotwald T, Matuja W, et al. (2008) Anticysticercal and antitoxocaral antibodies in people with epilepsy in rural Tanzania. Trans R Soc Trop Med Hyg 102: 1032-1038.
16. Blocher J, Schmutzhard E, Wilkins PP, Gupton PN, Schaffert M, et al. (2011) A cross-sectional study of people with epilepsy and neurocysticercosis in Tanzania: clinical characteristics and diagnostic approaches. PLoS neglected tropical diseases 5: e1185.
17. Winkler AS, Blocher J, Auer H, Gotwald T, Matuja W, et al. (2009) Epilepsy and neurocysticercosis in rural Tanzania-An imaging study. Epilepsia 50: 987-993.
18. Winkler AS, Schaffert M, Schmutzhard E, (2007) Epilepsy in resource poor countries-suggestion of an adjusted classification. Epilepsia 48: 1029-1030.
19. Mafojane NA, Appleton CC, Krecek RC, Michael LM, Willingham AL 3rd, (2003) The current status of neurocysticercosis in Eastern and Southern Africa. Acta Trop 87: 25-33.
20. Dorny P, Phiri IK, Vercruysse J, Gabriel S, Willingham AL 3rd, et al. (2004) A Bayesian approach for estimating values for prevalence and diagnostic test characteristics of porcine cysticercosis. Int J Parasitol 34: 569-576.
21. Sokal RR, Rohlf JF (1981) Biometry: the principals and practice of statistics in biological research. WH Freeman, New York.
22. R. (2011) A Language and Environment for Statistical Computing, R Development Core Team R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, http://www.R-project.org.2011.
23. Chang KH, Han MH, (1998) MRI of CNS parasitic diseases. J Magn Reson Imaging 8: 297-307.
24. Graeff-Teixeira C, da Silva AC, Yoshimura K, (2009) Update on eosinophilic meningoencephalitis and its clinical relevance. Clin Microbiol Rev 22: 322-348.
25. Martinez HR, Rangel-Guerra R, Elizondo G, Gonzalez J, Todd LE, et al. (1989) MR imaging in neurocysticercosis: a study of 56 cases. AJNR Am J Neuroradiol 10: 1011-1019.
26. Erhart A, Dorny P, Van De N, Vien HV, Thach DC, et al. (2002) Taenia solium cysticercosis in a village in northern Viet Nam: seroprevalence study using an ELISA for detecting circulating antigen. Trans R Soc Trop Med Hyg 96: 270-272.
27. Abraham R, Livramento JA, Leite Cda C, Pardini AX, Vaz AJ, et al. (2010) Neurocysticercosis: relationship between Taenia antigen levels in CSF and MRI. Arq Neuropsiquiatr 68: 7-11.
28. Rabiela MT, Rivas A, Flisser A, (1989) Morphological types of Taenia solium cysticerci. Parasitol Today 5: 357-359.
29. Rodriguez S, Dorny P, Tsang VC, Pretell EJ, Brandt J, et al. (2009) Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis 199: 1345-1352.
30. Ito A, Nakao M, Ito Y, Yuzawa I, Morishima H, et al. (1999) Neurocysticercosis case with a single cyst in the brain showing dramatic drop in specific antibody titers within 1 year after curative surgical resection. Parasitol Int 48: 95-99.
31. Winkler AS, Willingham AL 3rd, Sikasunge CS, Schmutzhard E, (2009) Epilepsy and neurocysticercosis in sub-Saharan Africa. Wien Klin Wochenschr 121 (Suppl 3):: 3-12.
32. Foyaca-Sibat H, Cowan LD, Carabin H, Targonska I, Anwary MA, et al. (2009) Accuracy of serological testing for the diagnosis of prevalent neurocysticercosis in outpatients with epilepsy, Eastern Cape Province, South Africa. PLoS neglected tropical diseases 3: e562.